Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Mersana Therapeutics Inc’s current trading price is -70.94% away from its 52-week high, while its distance from the 52-week low is 49.59%. The stock’s price range over this period has fluctuated between $1.22 and $6.28. The company, operating within the financial sector, had a trading volume of approximately 0.95 million for the day, which was noticeably lower than the average daily share volume of 1.02 million over the last 3 months.
Mersana Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $6.28 on 03/11/24, while the lowest price for the same period was registered at $1.22 on 08/14/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Mersana Therapeutics Inc (MRSN) has experienced a quarterly decline of -16.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 225.45M and boasts a workforce of 123 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.93, with a change in price of -0.19. Similarly, Mersana Therapeutics Inc recorded 1,080,287 in trading volume during the last 100 days, posting a change of -9.49%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MRSN stands at 30.00. Similarly, the long-term debt-to-equity ratio is also 15.51.
MRSN Stock Stochastic Average
Today’s raw stochastic average for Mersana Therapeutics Inc over the last 50 days is 3.62%.This indicates a increase from the raw stochastic average of the past 20 days, which was 0.23%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 9.61% and 18.48%, respectively.
MRSN Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -21.34%.However, over the last six months, we can see a stronger performance of -10.54%. Over the last 30 days, the price of MRSN has leaped by -13.51%. And in the last five days, it has fallen by -31.90%.
